Business · 17/08/2018Updated: 10/17/2026 · 1 min read
FDA Announces Proposed Collection of Information for Generic Drug Development
Summary
The Food and Drug Administration has submitted a proposed collection of information to the Office of Management and Budget for review and clearance, related to controlled correspondence for generic drug development.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →